1. Home
  2. HAS vs NBIX Comparison

HAS vs NBIX Comparison

Compare HAS & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hasbro Inc.

HAS

Hasbro Inc.

HOLD

Current Price

$91.69

Market Cap

13.2B

ML Signal

HOLD

Logo Neurocrine Biosciences Inc.

NBIX

Neurocrine Biosciences Inc.

HOLD

Current Price

$128.81

Market Cap

13.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HAS
NBIX
Founded
1923
1992
Country
United States
United States
Employees
N/A
N/A
Industry
Recreational Games/Products/Toys
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.2B
13.2B
IPO Year
1994
1996

Fundamental Metrics

Financial Performance
Metric
HAS
NBIX
Price
$91.69
$128.81
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
11
22
Target Price
$108.00
$180.36
AVG Volume (30 Days)
1.5M
906.6K
Earning Date
04-23-2026
05-04-2026
Dividend Yield
3.01%
N/A
EPS Growth
N/A
41.95
EPS
N/A
4.67
Revenue
$5,365,900,000.00
$161,626,000.00
Revenue This Year
$5.31
$22.85
Revenue Next Year
$6.54
$10.36
P/E Ratio
N/A
$28.21
Revenue Growth
13.06
977.51
52 Week Low
$50.55
$92.32
52 Week High
$106.98
$160.18

Technical Indicators

Market Signals
Indicator
HAS
NBIX
Relative Strength Index (RSI) 46.82 45.23
Support Level $87.60 $124.09
Resistance Level $94.35 $136.74
Average True Range (ATR) 2.46 4.22
MACD 0.25 0.16
Stochastic Oscillator 54.96 40.54

Price Performance

Historical Comparison
HAS
NBIX

About HAS Hasbro Inc.

Hasbro is a branded play company providing children and families around the world with entertainment offerings based on a world-class brand portfolio. From toys and games to television programming, motion pictures, and a licensing program, Hasbro reaches customers by leveraging its well-known brands such as Transformers, Peppa Pig, and Magic: The Gathering. The firm acquired EOne in 2019, bolting on popular family properties like Peppa Pig and PJ Masks, and has since divested noncore lines from the tie-up. Furthermore, the addition of Dungeons & Dragons Beyond in 2022 offers the firm access to 19 million digital tabletop players.

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes therapies for conditions such as tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, and treatments for endometriosis and uterine fibroids. The company also maintains a pipeline of drug candidates in various stages of clinical and preclinical development across its therapeutic areas, including small molecules, peptides, proteins, antibodies, conjugates, and gene therapies. It derives revenue from the sale of its pharmaceutical products.

Share on Social Networks: